Table 2.
Characteristics of relapse
| Nonseminoma | Seminoma | |
|---|---|---|
| Patients, n (%) | 26 (32) | 56 (68) |
| Median time from semicastration to relapse, mo (IQR) a | 4.6 (3.3–12.7) | 12.0 (6.9–18.1) |
| Initial disease stage, n (%) | ||
| Stage I | 20 (77) | 52 (93) |
| Stage IIA | 1 (4) | 0 |
| Stage IIB | 1 (4) | 2 (4) |
| Stage IIC | 0 | 0 |
| Stage III | 4 (15) | 2 (4) |
| Disease stage at relapse, n (%) b | ||
| Stage I S | 0 | 1 (3) |
| Stage IIA | 5 (33) | 13 (34) |
| Stage IIB | 3 (20) | 15 (40) |
| Stage IIC | 0 | 3 (8) |
| Stage III | 7 (47) | 6 (16) |
| Data missing | 0 | 1 |
| IGCCCG prognosis group at relapse, n (%) b | ||
| Good prognosis | 14 (93) | 33 (89) |
| Intermediate prognosis | 0 | 4 (11) |
| Poor prognosis | 1 (7) | 0 |
| Data missing | 0 | 2 |
IQR = interquartile range; IGCCCG = International Germ Cell Cancer Collaborative Group.
a
Excluding patients who entered the study <2 yr before analysis or lost to follow-up after <2 yr.
b
Only available for 54 patients who had a second entry in the trial database after treatment of relapse.